Inhibition of bone metastasis from breast cancer with pamidronate resulting in reduction of urinary pyridinoline and deoxypyridinoline in a rat model

Breast Cancer

Volumn 11, Issue 3, 2004, Pages 282-287

  Wada, Noriaki ^a,b   Ishii, Seiichiro ^c   Ikeda, Tadashi ^b   Kitajima, Masaki ^b  

^a NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^b KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KAWASAKI MUNICIPAL HOSPITAL   (Japan)

Author keywords

Bone metastasis; Breast cancer; Deoxypyridinoline; Pamidronate; Pyridinoline

Indexed keywords

AMINO ACID; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; DEOXYPYRIDINOLINE; PAMIDRONIC ACID; PYRIDINOLINE;

ANIMAL; ARTICLE; BLOOD; BONE TUMOR; BREAST TUMOR; COMPARATIVE STUDY; DISEASE MODEL; FEMALE; METASTASIS; PATHOLOGY; PROGNOSIS; RANDOMIZATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT OUTCOME; TUMOR CELL LINE; URINE;

AMINO ACIDS; ANIMALS; ANTINEOPLASTIC AGENTS; BONE NEOPLASMS; BREAST NEOPLASMS; CALCIUM; CELL LINE, TUMOR; DIPHOSPHONATES; DISEASE MODELS, ANIMAL; FEMALE; PROGNOSIS; RANDOM ALLOCATION; RATS; RATS, INBRED SHR; TREATMENT OUTCOME;

EID: 16644381026     PISSN: 13406868     EISSN: 18804233     Source Type: Journal    
DOI: 10.1007/BF02984550     Document Type: Article

References (26)

1. Boyde A, Maconnachie E, Reid SA, Delling G, Mundy GR: Scanning electron microscopy in bone pathology: review of methods, potential and applications. Scan Electron Microsc: 1537-1554, 1986. (Pubitemid 17224036)
2. Taube T, Elomaa I, Blomqvist C, Beneton MN, Kanis JA: Histomorphometric evidence for osteoclast-mediated bone resorption in metastatic breast cancer. Bone 15:161-166, 1994. (Pubitemid 24116079)
3. Hiraga T, Nakajima T, Ozawa H: Bone resorption induced by a metastatic human melanoma cell line. Bone 16:349-356, 1995.
4. Powell GJ, Southby J, Danks JA, Stillwell RG, Hayman JA, Henderson MA, Bennett RC, Martin TJ: Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. Cancer Res 51:3059-3061, 1991.
5. Mundy GR, Yoneda T: Facilitation and suppression of bone metastasis. Clin Orthop: 34-44, 1995.
6. Ishii S, Kitajima M: Mechanisms of bone metastasis using an animal model. Exp Med 12:1050-1054, 1994.
7. Tamura H, Ishii S, Ikeda T, Enornoto K, Imai Y, Kitajima M: A novel animal model for bone metastasis of breast cancer. Proc Am Assoc Cancer Res 34:97, 1993.
8. Tamura H, Ishii S, Ikeda T, Wada N, Enomoto K, Kitajima M: Therapeutic efficacy of pamidronate in combination with chemotherapy to bone metastasis of breast cancer in a rat model. Surg Oncol 5:141-147, 1996. (Pubitemid 26385515)
9. Yuhki N, Hamada J, Kuzumaki N, Takeichi N, Kobayashi H: Metastatic ability and expression of c-fos oncogene in cell clones of a spontaneous rat mammary tumor. Jpn J Cancer Res 77:9-12, 1986. (Pubitemid 16156032)
10. Katayama I, Yang JP: Reassessment of a cytochernical test for differential diagnosis of leukemic reticuloendotheliosis. Am J Clin Patho168:268-272, 1977. (Pubitemid 8140326)
11. Sekine K, Horie H, Hata K, Nanjo M, Sato K, Nishii Y, Yamamoto I, Morita R: Determination of pyridinoline and deoxypyridinoline in urine by high performance liquid chromatography with fluorometric detection. Rinsho Kagaku 21:18-25, 1992 (in Japanese).
12. Hall DG, Stoica G: Effect of the bisphosphonate risedronate on bone metastases in a rat mammary adenocarcinoma model system. J Bone Miner Res 9:221-230, 1994. (Pubitemid 24041567)
13. Kasting GB, Francis MD: Retention of etidronate in human, dog, and rat. J Bone Miner Res 7:513-522, 1992.
14. van der Pluijm G, Vloedgraven H, van Beck E, van der Wee-Pals L, Lowik C, Papapoulos S: Bisphosphonates inhibit the adhesion of breast cancer cells to bone matrices in vitro.J Clin Invest 98:698-705, 1996. (Pubitemid 26349174)
15. Boissier S, Magnetto S, Frappart L, Cuzin B, Ebetino FH, Delmas PD, Clezardin P: Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res 57:3890-3894, 1997. (Pubitemid 27427670)
16. Wingen F, Eichmann T, Manegold C, Krempien B: Effects of new bisphosphonic acids on tumor-induced bone destruction in the rat. J Cancer Res Clin Oncol 111:35-41, 1986. (Pubitemid 16161965)
17. Sasaki A, Boyce BF, Story B, Wright KR, Chapman M, Boyce R, Mundy GR, Yoneda T: Bisphosphonate risedronate reduces metastatic human breast cancer burden in bone in nude mice. Cancer Res 55:3551-3557, 1995.
18. Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF: Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478-1487, 1995.
19. Senaratne SG, Colston KW: Direct effects of bisphosphonates on breast cancer cells. Breast Cancer Res 4:18-23, 2002. (Pubitemid 34097552)
20. Fromigue O, Lagneaux L, Body JJ: Bisphosphonates induce breast cancer cell death in vitro. J Bone Miner Res 15:2211-2221, 2000.
21. Hiraga T, Williams PJ, Mundy GR, Yoneda T: The bisphosphonate ibandronate promotes apoptosis in MDA-MB-231 human breast cancer cells in bone metastases. Cancer Res 61:4418-4424, 2001. (Pubitemid 32685769)
22. Wada N, Fujisaki M, Ishii S, Ikeda T, Kitajima M: Evaluation of bone metabolic markers in breast cancer with bone metastasis. Breast Cancer 8:131-137, 2001.
23. Shimozuma K, Sonoo H, Fukunaga M, Ichihara K, Aoyama T, Tanaka K: Biochemical markers of bone turnover in breast cancer patients with bone metastases: a preliminary report. Jpn J Clin Onco129:16-22, 1999.
24. Nemoto R, Nakamura I, Nishijima Y, Shiobara K, Shimizu M, Takehara T, Ohta T, Kiyoki M: Serum pyridinoline crosslinks as markers of tumour-induced bone resorption. BrJ Uro180:274-280, 1997. (Pubitemid 28318896)
25. Wada N, Ishii S, Ikeda T, Enomoto K, Kitajima M: Serum tartrate resistant acid phosphatase as a potential marker of bone metastasis from breast cancer. Anticancer Res 19:4515-4521, 1999. (Pubitemid 30042817)
26. Tamura H, Ishii S, Ikeda T, Enomoto tL Kitajima M: The Relationship between Urinary Pyridinoline, Deoxypyridinoline and Bone Metastasis in a Rat Breast Cancer Model. Breast Cancer 6:23-28, 1999.